362 results on '"de Visser, Karin E."'
Search Results
2. PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial
3. Mechanisms driving the immunoregulatory function of cancer cells
4. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
5. IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer
6. Immunoediting instructs tumor metabolic reprogramming to support immune evasion
7. Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk
8. Tumor-educated Tregs drive organ-specific metastasis in breast cancer by impairing NK cells in the lymph node niche
9. MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling
10. Anticancer opportunities at every stage of chemokine function
11. Impact of cancer cell-intrinsic features on neutrophil behavior
12. Abstract A052: Dissecting the immune regulatory mechanisms of distinct PI3K alterations in invasive lobular carcinoma
13. Immune crosstalk in cancer progression and metastatic spread: a complex conversation
14. Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer
15. Transcriptional Signature Derived from Murine Tumor-Associated Macrophages Correlates with Poor Outcome in Breast Cancer Patients
16. Single-cell analysis of innate immune cell mechanics: an application to cancer immunology
17. p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cells
18. Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
19. Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis
20. Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
21. Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response
22. Neutrophils take a round-trip
23. Supplementary Tables 1 from Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features
24. Data from Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features
25. Supplementary Figures 1 from Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features
26. Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features
27. A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the Proliferation, Immune response and RNA splicing modules in breast cancer
28. Flow cytometry-based isolation of tumor-associated regulatory T cells and assessment of their suppressive potential
29. In vitro assessment of cancer cell-induced polarization of macrophages
30. Chimeric Papillomavirus Virus-Like Particles Elicit Antitumor Immunity against the E7 Oncoprotein in an HPV16 Tumor Model
31. Revving Up Dendritic Cells while Braking PD-L1 to Jump-Start the Cancer-Immunity Cycle Motor
32. How neutrophils promote metastasis
33. PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer:the GELATO trial
34. Neoadjuvant immune checkpoint blockade triggers persistent and systemic Treg activation which blunts therapeutic efficacy against metastatic spread of breast tumors
35. Supplementary Figure Legend from A Preclinical Mouse Model of Invasive Lobular Breast Cancer Metastasis
36. Supplementary Methods from A Preclinical Mouse Model of Invasive Lobular Breast Cancer Metastasis
37. Supplementary Table 1 from A Preclinical Mouse Model of Invasive Lobular Breast Cancer Metastasis
38. Supplementary Figure 1 from A Preclinical Mouse Model of Invasive Lobular Breast Cancer Metastasis
39. Data from A Preclinical Mouse Model of Invasive Lobular Breast Cancer Metastasis
40. Supplementary Figure 2 from A Preclinical Mouse Model of Invasive Lobular Breast Cancer Metastasis
41. Supplementary Figure 3 from A Preclinical Mouse Model of Invasive Lobular Breast Cancer Metastasis
42. Supplementary Figure 4 from A Preclinical Mouse Model of Invasive Lobular Breast Cancer Metastasis
43. Genetically engineered mouse models in oncology research and cancer medicine
44. Immune-mediated mechanisms influencing the efficacy of anti-cancer therapies
45. Utilizing Mouse Models of Human Cancer for Assessing Immune Modulation of Cancer Development
46. Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
47. Macrophages in tumour development and metastasis
48. Sticking together helps cancer to spread
49. Matrix Metalloproteinases: Mediators of Tumour-Host Cell Interactions
50. The lung fibroblast as “soil fertilizer” in breast cancer metastasis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.